An overview: The UK’s CBD market in 2022

UK's CBD Market

By any measure, the UK’s CBD market is growing.  Celebrity-backed brands, high street availability and the unlimited appeal of the next big thing in wellness continue to fuel demand for CBD products. Sales of CBD soared in the UK at the height of the pandemic and the size of the consumer cannabinoid sector is now […]

Celebrating 3 years of Naturecan

Naturecan co-founders Paul and Andrew pictured

Naturecan, the UK CBD brand born out of Stockport, is celebrating three years in business. We caught up with some of the team to look back on the highlights of the company’s journey so far.  It all started with a lightbulb moment in 2018, when Naturecan co-founder Paul Finnegan had an idea to create CBD […]

Goodbody Health’s Polish arm, Sativa Wellness, on ‘ultra-pure’ CBD

how 'ultra-pure' cbd is made from hemp

Cannabinoid Insight ‘met’ Dr Krzysztof Wojtanowski in March by video link. With the head office based in the UK, Goodbody Health has acquired Sativa Wellness, in Bilcza, south-central Poland, where the main focus is on the production of ultra-pure CBD isolate and broad-spectrum THC-free distillate. Both are compliant with ISO 22000 Food Safety Management procedures. […]

The CBD list in numbers

the CBD list in numbers

Cannabinoid Insight has monitored the various numbers and statements made since the publication of the CBD list by the Food Standards Agency (FSA) in March. Here is how things stand in April 2022, in the weeks after the list went live. Since 1 January 2021, the FSA has received over 900 novel food applications for CBD […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]